In 2024, Bloomfield saw Medicaid payments reaching at least $59,028 for services tied to HCPCS codes specifically connected to COVID-19, based on the U.S. Department of Health and Human Services Medicaid Provider Spending database.
Medicaid is a joint state and federally funded public insurance program that serves low-income residents, seniors, children and individuals with disabilities, playing a major role in the U.S. health care landscape. More details about Medicaid can be found here.
Because taxpayer money underwrites Medicaid, fluctuations in local billing can highlight how resources for public health care are distributed within a community.
COVID-related services for this analysis were classified by using HCPCS codes either identified or marked as “COVID-19”- or “coronavirus”-related in their billing descriptors or reference data. Consequently, results only account for those services directly labeled in claims as COVID-19 related, and do not encompass care connected to the pandemic that might fall under broader billing codes.
To provide comparison, Avon recorded the highest amount of Medicaid payments for COVID-19–related services in Connecticut in 2024, with $554,621 in claims attributed to the virus.
For additional context, Medicaid providers in Bloomfield received on average $29,514 per provider for COVID-19–related services, above the Connecticut state average of $29,059.
Throughout the pandemic years, distinct COVID-19 services contributed noticeably to increased Medicaid expenditures in Bloomfield.
Total payments for all other types of Medicaid claims grew by $1,446,788 from 2020 to 2024, reflecting a 42.6% rise during that period.
In the two years prior to the outbreak, annual average Medicaid payments in Bloomfield totaled $3,306,664.
According to the Centers for Medicare & Medicaid Services, combined federal and state spending on Medicaid reached approximately $871.7 billion in fiscal year 2023, making up nearly 18% of the nation’s total health care expenditures—a significant increase from $613.5 billion in 2019, before the onset of the COVID-19 pandemic.
This uptick reflects about 40% growth in a few years, largely fueled by greater enrollment and utilization rates during and after the pandemic.
Recent federal budget measures under the Trump administration have proposed major reductions in Medicaid funding and structural changes to the program. The “One Big Beautiful Bill Act,” passed in 2025, is slated to reduce federal Medicaid expenditures by more than $1 trillion over the next 10 years. The law also introduces requirements such as mandatory work and higher cost-sharing, which could restrict access and funding for some people. As federal fiscal support for Medicaid may slow, more of the program’s financial burden could shift to states, even as it covers tens of millions across the country.
| Year | COVID-19–Related Payments | COVID-19 Payments % Change (YoY) | Total Medicaid Payments |
|---|---|---|---|
| 2024 | $59,028 | -53.3% | $4,900,164 |
| 2023 | $126,324 | -47.6% | $6,946,623 |
| 2022 | $241,077 | 10.8% | $6,968,324 |
| 2021 | $217,589 | 9,948.9% | $7,317,267 |
| 2020 | $2,165 | N/A | $3,396,514 |
| 2019 | $0 | N/A | $3,437,522 |
| 2018 | $0 | N/A | $3,175,807 |
| HCPCS Code | Description | Medicaid Payments | Claims |
|---|---|---|---|
| 87811 | Immunoassay | $59,028 | 2,264 |
Note: Includes HCPCS codes explicitly labeled for COVID-19 services; totals do not represent all pandemic-related health care spending.
This report draws on data from the U.S. Department of Health and Human Services Medicaid Provider Spending database. Source information is available here.
